Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial.

ABSTRACT:

Purpose

To evaluate the therapeutic effect of intravitreal triamcinolone (IVT) injection for recent branch retinal vein occlusion (BRVO).

Methods

In a randomized controlled clinical trial, 30 phakic eyes with recent (less than 10 weeks' duration) BRVO were assigned to two groups. The treatment group (16 eyes) received 4 mg IVT and the control group (14 eyes) received subconjunctival sham injections. Changes in visual acuity (VA) were the main outcome measure.

Results

VA and central macular thickness (CMT) changes were not significantly different between the study groups at any time point. Within group analysis showed significant VA improvement from baseline in the IVT group up to three months (P < 0.05); the amount of this change was -0.53 ± 0.46, -0.37 ± 0.50, -0.46

SUBMITTER: Ramezani A 

PROVIDER: S-EPMC3306087 | biostudies-literature | 2011 Apr

REPOSITORIES: biostudies-literature